| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5565447 | JANSSEN PHARMS | Indole derivatives |
May, 2015
(8 years ago) | |
|
US5565447 (Pediatric) | JANSSEN PHARMS | Indole derivatives |
Nov, 2015
(8 years ago) | |
Axert is owned by Janssen Pharms.
Axert contains Almotriptan Malate.
Axert has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Axert are:
- US5565447
- US5565447*PED
Axert was authorised for market use on 07 May, 2001.
Axert is available in tablet;oral dosage forms.
Axert can be used as treatment of migraine.
The generics of Axert are possible to be released after 07 November, 2015.
Drugs and Companies using ALMOTRIPTAN MALATE ingredient
Market Authorisation Date: 07 May, 2001
Treatment: Treatment of migraine
Dosage: TABLET;ORAL
How can I launch a generic of AXERT before it's drug patent expiration?
More Information on Dosage
AXERT family patents
